Efficacy, predictability and safety of long-term orthokeratology: An 18-year follow-up study

角膜塑形术 正视 医学 入射(几何) 视力 眼科 人口统计学的 折射误差 角膜 人口学 物理 社会学 光学
作者
Joan Gispets,Pilar Yébana,Núria Lupón,Genı́s Cardona,Joan Pérez-Corral,Jaume Pauné,Bernat Cortilla
出处
期刊:Contact Lens and Anterior Eye [Elsevier BV]
卷期号:45 (1): 101530-101530 被引量:22
标识
DOI:10.1016/j.clae.2021.101530
摘要

To determine the efficacy, predictability and safety of long-term orthokeratology in children and adults.Case histories of 300 orthokeratology patients (596 eyes; 34.3% children; 65.7% adults) were reviewed to collect information on demographics, corneal and refractive parameters, visual acuity, residual refraction and adverse effects. Predictability was defined as the percentage of eyes with absolute values of spherical equivalent refraction ≤ 0.5 D of emmetropia, and efficacy as the ratio of post-orthokeratology uncorrected and pre-orthokeratology corrected distance visual acuity.Median duration of treatment was 37 and 28.5 months in children and adults, respectively (p = 0.022). During the first year, 17.2% of children and 33% of adults ceased lens wear (p < 0.001). For children and adults with a successful ortho-k treatment of at least one year of duration, 88.7% and 95.9% of eyes had a predictable refractive outcome, and efficacy was 0.98 and 1.01, respectively. A larger percentage of children (65.7%) were free of complications than of adults (55.4%) (p = 0.015). One event of microbial keratitis occurred in adults (6.8 cases per 10,000 patient-years) and none in children. Corneal staining was the most frequent complication, with a higher incidence in adults (p = 0.007) and in higher myopia (p < 0.001), higher anterior corneal eccentricity (p = 0.019) and smaller anterior horizontal radius (p = 0.027).Orthokeratology is a safe and predictable long-term procedure in children and adults, with a low incidence of serious adverse effects. Corneal staining episodes are relatively frequent throughout the course of the treatment, thus highlighting the relevance of education of experienced users.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
爆米花的应助被科研通管家采纳,获得10
刚刚
坚强冰枫的应助被科研通管家采纳,获得10
刚刚
哈哈发布了新的文献求助10
1秒前
Ava的应助被科研通管家采纳,获得10
1秒前
小马甲的应助被科研通管家采纳,获得10
1秒前
invisight的应助被科研通管家采纳,获得10
1秒前
搜集达人的应助被科研通管家采纳,获得10
1秒前
斯文败类的应助被科研通管家采纳,获得10
1秒前
zsm完成签到 ,获得积分10
1秒前
null的应助被科研通管家采纳,获得10
1秒前
1秒前
挚友发布了新的文献求助20
2秒前
poison发布了新的文献求助10
2秒前
3秒前
3秒前
无心的翰完成签到,获得积分10
3秒前
彩色豁发布了新的文献求助10
4秒前
4秒前
5秒前
5秒前
5秒前
呆萌的xue发布了新的文献求助10
6秒前
Moon完成签到,获得积分10
6秒前
6秒前
任性山芙发布了新的文献求助10
7秒前
大力可燕完成签到,获得积分10
9秒前
科西西发布了新的文献求助10
9秒前
9秒前
hhhh完成签到,获得积分10
9秒前
超级寒凝完成签到,获得积分20
9秒前
9秒前
木木很累发布了新的文献求助10
10秒前
ektssw完成签到 ,获得积分10
10秒前
v0id的应助被zorro3574采纳,获得10
10秒前
tianzhen发布了新的文献求助10
10秒前
TRACEY发布了新的文献求助10
10秒前
科研通AI6.4的应助被Oo采纳,获得10
12秒前
任性山芙完成签到,获得积分10
13秒前
yanann完成签到 ,获得积分10
13秒前
13秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Campbell's Operative Orthopaedics, E-Book 3000
Les Mantodea De Guyane 2000
Energie-Contracting 1500
内視鏡下経鼻経蝶形骨洞手術術後SIADHに対する予防的水制限の安全性と有効性の検討 1000
Positive Psychology 600
Guidelines for fracture-safe and fatigue-reliable design of steel structures 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8012147
求助须知:如何正确求助?哪些是违规求助? 9460002
关于积分的说明 21180377
捐赠科研通 7583209
什么是DOI,文献DOI怎么找? 3383856
关于科研通互助平台的介绍 2516069
邀请新用户注册赠送积分活动 2419076